RAP 0.00% 20.5¢ resapp health limited

2020 commercialisation, page-605

  1. 26,830 Posts.
    lightbulb Created with Sketch. 1738
    The FDA is looking for evidence of human factor which is the additional information that they requested late December after 8 months of review, hence these commercialisation will be evidence of this.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.